Rhabdomyolysis Associated with Antimicrobial Drug–Resistant Mycoplasma pneumoniae

Abstract

We describe a case of rhabdomyolysis in a patient infected with antimicrobial drug–resistant Mycoplasma pneumoniae The patient’s acute-phase serum levels of interleukin-18 and tumor necrosis factor–α were high, which suggests a pathogenic role for M. pneumoniae. In an era of increasing antimicrobial drug resistance, a system for rapidly identifying resistant M. pneumoniae would be beneficial.

Keywords

• rhabdomyolysis
• antimicrobial resistance
• Mycoplasma pneumoniae
• bacteria
• ribosome
• mutation